Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism. (Record no. 21331653)

MARC details
000 -LEADER
fixed length control field 01997 a2200577 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516064707.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201202s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1524-4539
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1161/CIRCULATIONAHA.111.047100
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Orbe, J
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20120216
245 00 - TITLE STATEMENT
Title Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Circulation
Date of publication, distribution, etc. Dec 2011
300 ## - PHYSICAL DESCRIPTION
Extent 2909-19 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bleeding Time
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Brain Ischemia
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carotid Artery Diseases
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cerebral Hemorrhage
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cerebral Infarction
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease Models, Animal
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Extracellular Matrix
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fibrinolysis
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fibrinolytic Agents
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Intracranial Thrombosis
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Matrix Metalloproteinase 10
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mice
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mice, Inbred C57BL
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mice, Mutant Strains
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Stroke
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thrombin
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tissue Plasminogen Activator
General subdivision pharmacology
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Barrenetxe, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rodriguez, J A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vivien, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Orset, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Parks, W C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Birkland, T P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Serrano, R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Purroy, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Martinez de Lizarrondo, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Angles-Cano, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Páramo, J A
773 0# - HOST ITEM ENTRY
Title Circulation
Related parts vol. 124
-- no. 25
-- p. 2909-19
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1161/CIRCULATIONAHA.111.047100">https://doi.org/10.1161/CIRCULATIONAHA.111.047100</a>
Public note Available from publisher's website

No items available.